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Abstract
Tularemia is a serious, potentially life threatening zoonotic disease. The causative agent, Francisella tularensis, is
ubiquitous in the Northern hemisphere, including Alaska, where it was first isolated from a rabbit tick (Haemophysalis
leporis-palustris) in 1938. Since then, F. tularensis has been isolated from wildlife and humans throughout the state.
Serologic surveys have found measurable antibodies with prevalence ranging from < 1% to 50% and 4% to 18% for
selected populations of wildlife species and humans, respectively. We reviewed and summarized known literature on
tularemia surveillance in Alaska and summarized the epidemiological information on human cases reported to public
health officials. Additionally, available F. tularensis isolates from Alaska were analyzed using canonical SNPs and a
multi-locus variable-number tandem repeats (VNTR) analysis (MLVA) system. The results show that both F. t. tularensis
and F. t. holarctica are present in Alaska and that subtype A.I, the most virulent type, is responsible for most recently
reported human clinical cases in the state.
Introduction
Tularemia is a serious and potentially life threatening zoo-
notic disease caused by the Gram-negative bacterium
Francisella tularensis. Due to its high virulence and zoo-
notic potential, F. tularensis is listed as a category A select
bioterrorism agent. F. tularensis has been weaponized in
the past by the United States, Japan, the former USSR, and
potentially other countries [1]. The organism was first iso-
lated from a ground squirrel in 1911 in Tulare County,
CA. It was named Bacterium tularense, was later reclassi-
fied as Pasteurella tularense, and finally, in 1966, was
named Francisella tularensis after Edward Francis.
Descriptions of a plague-like disease now considered to be
tularemia predate this first isolation, going as far back as
1818 in Japan [2]. The first laboratory-confirmed human
case was reported in 1914 [3]. Since then F. tularensis has
been isolated from more than 250 host species [4].
F. tularensis is ubiquitous in the Northern hemisphere
and currently there are four recognized subspecies.
F. tularensis subsp. tularensis (type A) is the most virulent
of subspecies and is found throughout North America.
F. tularensis subsp. holarctica (type B) is less virulent and
is found throughout the Northern hemisphere. The dis-
tinction between type A and B tularemia was first made in
the middle of the 20th century [5]. Type A is divided into
types A.I and A.II, and A.I is still further divided into types
A.Ia and A.Ib. In a review of isolates collected in the US
over 40 years, the highest human mortality rate was asso-
ciated with type A.Ib (12/49 or 24%), followed by type B
(8/108 or 7%), type A.Ia (2/55 or 4%), and finally, type A.II
(0/53 or 0%)[6]. The third subspecies, F. tularensis subsp.
mediasiatica is virulent and has been isolated in central
Asia. Finally, many consider F. tularensis subsp. novicida
to be a fourth subspecies of F. tularensis based on genetics
and biochemical requirements [7], though this classifica-
tion is still disputed [8,9]. F. tularensis subsp novicida is
generally avirulent in humans and is distributed globally
[2,10].
The disease caused by F. tularensis depends on the route
of entry. Ulceroglandular tularemia, the most common
form of disease, results from exposure through the skin
(either preexisting wound or arthropod bite). This form
results in an ulcer at the site of infection followed by lym-
phadenopathy. Pneumonic tularemia, the most serious
form of disease, results from inhalation of aerosolized bac-
teria. Other forms of the disease include oculoglandular
(exposure via the eye), oropharyngeal (ingestion), and
typhoidal tularemia (systemic infection without a primary
ulcer).
Here we review the history of tularemia in both wildlife
and humans in the state of Alaska. We also report on the
genetic characterization of recent Alaskan F. tularensis
human and animal isolates using canonical SNPs
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(canSNPs) and multi-locus variable tandem repeat
(VNTR) analysis (MLVA).
Tularemia in wildlife in Alaska
In Alaska, F. tularensis was first isolated from a rabbit tick
(Haemophysalis leporis-palustris) removed from a varying
hare (Lepus americanus) near Fairbanks in 1938 [11]. The
isolated strain was virulent in both guinea pigs and rabbits,
resulting in enlarged spleens and areas of focal necrosis in
both the spleens and livers. The high virulence in both
species suggests that the isolate may have been type A.
Later, an additional two virulent and likely type A isolates
were obtained when suspensions of ground ticks removed
from two healthy hares were inoculated into guinea pigs
[12,13]. Isolates collected from subsequent animals indi-
cated the presence of a less virulent type, likely type B.
The first of these was an isolate obtained from ticks col-
lected from willow ptarmigan (Lagopus lagopus) in the
Fairbanks area in 1959 [14]. Voles sampled during the
summer of 1963 on the Alaska Peninsula revealed a large
number with splenomegaly and resulted in the isolation of
another less virulent isolate [15]. During the summer of
1971 in the Fairbanks area, 10 of 24 hares had enlarged
spleens from which F. tularensis was isolated [16]. This
isolate was compared to the vole isolate from 1963 [15]
and shown to be significantly more virulent in challenge
studies, further supporting the coexistence of type A and
B strains in Alaska [16] (Table 1).
Though few isolates have been obtained, serological
surveys for tularemia conducted between 1964 and 2000
have indicated the presence of F. tularensis among a
wide variety of wildlife species and across a wide geo-
graphic area in Alaska. Seropositive animals (titer ≥ 1:20)
in these surveys included various rodents and hares,
birds and large predators (Table 2). Of those titers
reported, the range was 1:20 - 1:320 [14,17-20]. These
serology results are consistent with the wide number of
species in which F. tularensis has been found [4], but
revealed few clues as to the important reservoir(s) for
F. tularensis in Alaska. Of note, however, were two stu-
dies by Zarnke et al. [19,20], which found that positive
tularemia serology peaks in predators followed peaks in
snowshoe hare populations, suggesting the possibility of
a hare reservoir. In addition, F. tularensis DNA was
found in 30% of > 2500 mosquitoes in Alaska, suggesting
the possibility of an arthropod reservoir as well [21].
History of human tularemia in Alaska
The first possible case of human tularemia in Alaska was
reported in 1938 in a 62-year-old man from Wiseman,
north of the Arctic Circle. The patient exhibited symp-
toms of ulceroglandular tularemia and was hospitalized
for 2 months, though there was no laboratory confirma-
tion of tularemia [13]. In 1946, a 31-year-old male from
Northway (interior Alaska) with a history of skinning
muskrats became the first laboratory-confirmed case by
serology (titer 1:1280). His symptoms were headache, orbi-
tal pain, general aches and fever followed by development
of swollen lymph nodes. The patient also reported that an
ulcerated lesion had been present on his left middle finger
for about one week. However, no isolate was cultured [22].
The first culture positive human infection occurred in
1974 in a 42-year-old laboratory worker with pneumonia
whose pleural fluid yielded an isolate of F. tularensis [23].
Following the diagnosis of these initial cases of tulare-
mia, surveillance projects were conducted throughout the
state. The first of these occurred between 1954 and 1957
and involved 816 skin tests of inhabitants of Alaskan
villages, of which 64 (8%) were positive, with 50 - 59 year
olds having the highest incidence by age group [24]. The
highest incidence was found in central Alaska, between
Minto and Kaltag and as far north as Hughes, correspond-
ing with the rich trapping areas in central Alaska. Follow-
ing this initial surveillance, two additional surveys of
Alaska Natives were completed. First, in the 1960s, serolo-
gical surveys of 793 Aleut, Indian and Eskimo men showed
an overall detection rate of 18% (139 of 793), with titers
ranging from 1:20 to 1:640. A second survey involved skin
tests on a subset of 115 (15%) of these Alaska Natives.
Fifty-one (44%) of the 115 had positive skin tests, 43 (84%)
of which also had detectable titers in the first survey, indi-
cating a high correlation between skin test and titer
results. Following these results, questionnaires were com-
pleted to determine if clinical disease resembling tularemia
had been present. No difference in either total illness or
tularemia-like illness was found between seropositive and
seronegative groups, suggesting that the tularemia present
in Alaska Natives may be of a less virulent type [25].
Table 1 Isolation of Francisella tularensis in Alaskan wildlife from 1938-1974
Year Host Location # Positive # Collected Reference
1938 Rabbit Tick Fairbanks 3 lots 3 lots 11
1953 Rabbit Tick Minto, Livengood, Fairbanks 3 lots 14 lots 12
1960 Tick (from ptarmigan) Livengood 1 lot Unknown 24
1963 Red-backed vole Alaska Peninsula 1 217 15
1971 Varying hare Fairbanks 1 24 16
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A final survey of Alaska Natives was completed in
1974. In this study, there were 4% (29 of 810) and 7% (28
of 402) positive titer rates (≥ 1:80, range 1:80-1:1280) in
southwestern and east central Alaska, respectively. In
addition, two seroconversions in children were documen-
ted (both > 4-fold increase in titer), with one child
reporting a rash at around the time of the rise in titer
and the other exhibiting no signs of disease. Similar to
the previous surveys, no cases of tularemia-like illness
were described in the villages studied, again suggesting
that the tularemia present in these villagers was due to a
less virulent type, that the route of infection favors
asymptomatic disease or that Alaska Natives have devel-
oped resistance [23].
Table 2 Prevalence of Francisella tularensis antibodies (titer ≥ 1:20) in Alaskan wildlife from 1964 - 2000
Year Host Location #Positive #Tested Reference
1964 Dairy cattle Tanana Valley 2 173 [14]
Barrow ground squirrel Tanana hills, Paxson 1 34
Red squirrel Interior, Paxson 9 111
Red-backed vole Interior, Paxson 2 120
Tundra vole Interior, Paxson 11 229
Porcupine Interior 1 2
Varying hare Interior, Paxson 3 60
Cliff swallow Interior 1 3
Bank swallow Interior 1 38
Common redpoll Interior, Paxson 1 15
Varied thrush Interior 1 4
Northern water thrush Tanana hills 1 3
American tree sparrow Tanana hills 1 10
Willow ptarmigan Tanana hills 1 2
1967-68 Varying hare Eagle 1 29 [18]
Ground squirrel Denali highway 2 72
Red-backed vole Delta creek 1 376
Collared lemming Nome 1 25
Wolf Tok 1 15
Black bear Circle hot springs 2 4
Marten Eagle 9 26
Ermine Katella 1 31
Lynx Tok 1 4
Gray jay Manley hot springs 2 19
Northern raven Circle hot springs, Fairbanks 2 13
Northern shrike Glenn highway 1 1
1975-82 Wolf Southcentral Alaska 16 67 [19]
1984- Wolf Southcentral Alaska 1 6 [20]
2000 Wolf Central Interior 8 32
Wolf Southern Interior 28 135
Wolf Eastern Interior 2 30
Wolf Western Interior 3 30
Wolf Northern Interior 7 48
Wolf Western arctic 5 75
Wolf Eastern arctic 2 45
1988-91 Grizzly bear Kodiak island 3 77 [17]
Grizzly bear Alaska Peninsula 12 86
Grizzly bear Interior Alaska 13 40
Black bear Interior Alaska 13 40
Grizzly bear Seward Peninsula 4 40
Grizzly bear Noatak river drainage 12 87
Grizzly bear Arctic northwest 34 96
Grizzly bear Arctic northeast and central 15 54
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In 1993, two human cases related to housecats
occurred in Fairbanks. One patient was a 44-year-old
man who had been bitten on the thumb by his cat three
and a half weeks prior to admission. Prior to the man’s
illness, his cat had been seen by a veterinarian and trea-
ted with antibiotics for an unknown febrile illness. The
second patient was a 42-year-old veterinarian who pre-
sented with similar symptoms. The veterinarian had trea-
ted several cats with tularemia during the two-month
period prior to his illness. Both human cases resolved
with appropriate antibiotics [26].
Following the above housecat-associated cases, a serolo-
gical survey of veterinarians was done in the Fairbanks
area; two of 14 veterinarians (14%) had positive titers (≥
1:80) for tularemia. Questionnaires sent to Fairbanks phy-
sicians and veterinarians indicated that 54% (15/28) and
92% (11/12), respectively, were aware that tularemia was
prevalent in local wildlife. In addition, nine veterinarians
had treated local domestic cats or dogs for suspected
tularemia, indicating that household pets can pose a signif-
icant source for human infection [26].
Epidemiology of reported human cases in Alaska 1946-2010
Between 1946 and 2010, a total of 38 cases of tularemia
were known to public health authorities in Alaska, with 9
cases in the Fairbanks-Steese area between 1946 and 1953
[27] and an additional 29 cases from throughout the entire
state between 1972 and 2009. Of the 38 reported cases, 23
were laboratory confirmed, with detailed laboratory data
available for 19 of those 23. Of these 19, 10 had four-fold
changes in paired titers, 7 had positive cultures for F tular-
ensis, 1 had a positive lymph node stain and 1 had a single
high titer along with clinical and epidemiological evidence.
Seventy-three percent (22 of 30) of the patients were male
with a median age of 39 years (range of 15-59 years).
Seventy-one percent (27 of 38) were white and 16% (6 of
38) were of unknown race. Most (69%, 20 of 29) had illness
onsets between June and August. Geographically, 68% (26
of 38) were exposed in central eastern Alaska, 21% (8 of
38) in the greater Anchorage area, 5% (2 of 38) in north-
western Alaska, 3% (1 of 38) in Southeastern Alaska and
3% (1 of 38) were exposed out-of-state. Ulceroglandular
tularemia was most common (70%, 19 of 27), followed by
typhoidal (11%, 3 of 27) and pneumonic (7%, 2 of 27) tular-
emia. None of the cases were fatal. Of those case-patients
with detailed exposure histories, 79% (19 of 24) had direct
contact with animals and 84% (16 of 19) of those had con-
tact with a known wildlife reservoir (Figure 1). The remain-
ing 16% (3 of 19) had had contact with domestic animals
(one cat bite and two dogs known to have killed hares).
Molecular subtyping of recent F. tularensis isolates
We subtyped DNAs from eight recent (2003-2009)
F. tularensis isolates (6 hare and 2 human) obtained by the
public health laboratory of Alaska from interior Alaska
and an additional four Alaskan DNAs (3 human and 1
?????????
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Figure 1 Number of human tularemia cases in Alaska reporting animal exposure.
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rodent) available in Northern Arizona University’s
F. tularensis DNA collection to determine if the presumed
coexistence of types A and B in Alaska could be con-
firmed. We first subtyped the isolate DNAs using a set of
canSNPs described by Vogler et al. [28] to identify the
major F. tularensis subclades found in Alaska. We then
subtyped the isolate DNAs using the MLVA system
described by Vogler et. al. [29] in order to identify addi-
tional variation among the isolates.
The canSNP analysis identified 10 isolates as type A.I (6
hares, 1 rodent, 3 human), one as type A.II (human), and
one as type B (human) (Figure 2). The canSNP assays
further placed the type A.I isolates into subclade A.I.
Br.001/002, the type A.II isolate into subclade A.II.Br.006/
007 and the type B isolate into subclade B.Br.OR96-0246.
This built upon a previous global analysis of F. tularensis,
which had identified a single subclade A.I.Br.001/002 iso-
late (also included in this study) in Alaska [28]. This
genetic analysis confirmed the previous virulence studies
that had suggested the coexistence of types A and B in
Alaska. Indeed, this analysis revealed an even greater level
of genetic diversity than previously suspected, in that
members of three major genetic groups were found to be
present. The fact that most of these isolates were type A.I
is likely related to the greater virulence of this genetic
group [6] and thus the greater likelihood of severe disease
and resultant opportunities for obtaining isolates through
the public health system. However it is also possible that
different strains are distributed differently throughout the
environment, or that the reservoirs are distributed differ-
ently. It is probable that types B and A.II are present in
much higher proportions in the wild than is indicated by
this analysis. By relying on clinical isolates for genetic ana-
lysis we are limited to strains that are more likely to cause
disease. Intensive sampling efforts would be needed to
obtain more isolates from wildlife or people in the state.
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Figure 2 Neighbor-joining dendrogram of Alaskan and 34 additional subclade A.I.Br.001/002 F. tularensis isolates based upon MLVA
data. The dendrogram was generated using neighbor-joining analysis of mean character differences using PAUP 4.0b10 (D. Swofford, Sinauer
Associates, Inc., Sunderland, MA). Bootstrap values ≥50, also generated using PAUP 4.0b10, are indicated and were based upon 1,000 simulations.
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The MLVA analysis revealed additional genetic diversity
among the Alaskan isolates. Specifically, a neighbor-join-
ing analysis based on MLVA data for the Alaskan isolates
and an additional 34 A.I.Br.001/002 isolates revealed that
the Alaskan subclade A.I.Br.001/002 isolates did not form
a monophyletic group. Rather, they were scattered
amongst subclade A.I.Br.001/002 isolates from diverse
North American geographic locations (Figure 2), indicat-
ing a relatively high level of genetic diversity within this
subclade in Alaska. This relatively high level of genetic
diversity suggests either multiple introductions of F. tular-
ensis to Alaska, a long history of F. tularensis in Alaska
with ample time for diversification and possible transfers
to other geographic locations, or a combination of the
two. However, it is important to note that such high levels
of genetic diversity within a single geographic location are
not unique to Alaska, having been observed elsewhere in
North America [28]. Additional whole genome sequen-
cing, SNP discovery and SNP screening as well as
increased sampling will likely be needed to determine the
origins and spread of F. tularensis in North America as a
whole and Alaska specifically.
Interestingly, though there was no obvious geographic
separation among the different Alaskan subclade A.I.
Br.001/002 MLVA genotypes as they were all collected
from Interior Alaska, the single Alaskan type A.II isolate
was geographically separated from the other Alaskan iso-
lates. The type A.II isolate (human) was isolated from the
Matanuska Susitna Valley whereas most of the other iso-
lates were from interior Alaska, where most tularemia
cases occur. These two regions are separated by the Alaska
Range, which might serve as a geographic barrier separat-
ing type A.II F. tularensis from other F. tularensis genetic
types in Alaska. However, this hypothesis would need to
be confirmed by genotyping more isolates from both geo-
graphic regions.
Conclusions
We have reviewed a history of F. tularensis in Alaska,
beginning with its first isolation in a group of hare ticks in
1938 and progressing to its molecular characterization in
2011. Only limited studies have taken place within the
state, there is still much to be learned about the ecology
and epidemiology of tularemia, particularly in northern cli-
mates where it is endemic. We still do not know the reser-
voir in Alaska, though it is suspected to be hares or
muskrats. We also do not know the prevalence of tulare-
mia in most of the wildlife in the state. Overall the pre-
sented work suggests the need for renewed serological
surveillance in both wildlife and humans to assess possible
changes in Francisella prevalence in a rapidly changing
Arctic. The current distribution of tularemia in Alaska is
not well understood. While most cases are reported from
Interior Alaska, while distribution of cases in wildlife or
subclinical human cases is not known. In addition more
molecular work is warranted to better understand the
strains circulating in Alaska and assess potential for
human infection associated with different host species.
Transstadial transmission of tularemia should be
addressed similar to work done in Sweden [30]. These
steps will further increase our understanding of tularemia
in Alaska and can guide public health surveillance and
intervention.
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